ZURICH (Reuters) - Roche said on Friday that European regulators had recommended approval of its drug Avastin as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/Hiq2VXLEuZU/story01.htm
Read More
No comments:
Post a Comment